Cardinal Health vs Roche: Founders, CEOs and History
Cardinal Health was founded in 1971 by Robert D. Walter and is led by Jason M. Hollar. Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker.
Company facts
Cardinal Health
- Founded
- 1971
- Headquarters
- Dublin, Ohio, United States
- Current CEO
- Jason M. Hollar
- Employees
- 63,900
Roche
- Founded
- 1896
- Headquarters
- Basel, Switzerland
- Current CEO
- Thomas Schinecker
- Employees
- 112,774
Founders
Cardinal Health
Robert D. Walter
Cardinal Health possesses a unique and unexpected founding history: the pharmaceutical distributor was not founded by a doctor or a pharmacist, but rather by an ambitious entrepreneur attempting to consolidate the wholesale food industry.
Roche
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.
CEOs and their tenures
Cardinal Health
- Robert D. Walter1971–2006
Founder, Chairman, and CEO
Walter founded Cardinal Health in 1971 as a food wholesaler and pivoted to pharmaceutical distribution in 1979. He executed dozens of acquisitions that transformed the company from a small regional distributor into a $50+ billion healthcare conglomerate.
Source - Kerry Clark2006–2009
Chairman and CEO
Clark led Cardinal Health through a period of strategic repositioning, including the spin-off of the CareFusion medical technology business. He focused on improving operational efficiency and addressing the challenges of the post-Walter era.
Source - George Barrett2009–2017
Chairman and CEO
Barrett led Cardinal Health through significant strategic initiatives including the acquisition of the Patient Recovery business from Medtronic ($6.1 billion) and the establishment of the Red Oak Sourcing joint venture with CVS Health.
Source - Mike Kaufmann2018–2022
CEO
Kaufmann led Cardinal Health through the opioid litigation settlement and the COVID-19 pandemic, which created demand for medical supplies and pharmaceuticals. He focused on operational execution and maintaining supply chain continuity during the crisis.
Source - Jason M. Hollar2022–present
CEO
Hollar joined Cardinal Health as CFO in 2020 and became CEO in September 2022. He has led the company through the OptumRx contract exit, the GMPD improvement plan, and acquisitions including GI Alliance, ADSG, and Solaris Health.
Source
Roche
- Severin Schwan2008–2023
Chief Executive Officer
Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.
Source - Thomas Schinecker2023–present
Chief Executive Officer
Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.
Source
Timeline: Cardinal Health and Roche side by side
1896Roche
F. Hoffmann-La Roche Founded in Basel
Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.
1898Roche
Commercial Breakthrough with Sirolin
Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.
1934Roche
First Industrial Synthesis of Vitamin C
Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.
1963Roche
Launch of Valium (Diazepam)
Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.
1968Roche
Establishment of Roche Diagnostics
Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.
1971Cardinal Health
Cardinal Foods Founded by Robert D. Walter
Robert D. Walter, a 26-year-old Harvard MBA graduate, borrowed $1.3 million to acquire the food-distribution division of Consolidated Foods in a leveraged buyout, establishing Cardinal Foods in Columbus, Ohio.
1979Cardinal Health
Pivot to Pharmaceutical Distribution
Walter acquired Bailey Drug Co., a pharmaceutical distributor in Zanesville, Ohio, marking Cardinal's entry into pharmaceutical distribution.
1983Cardinal Health
Cardinal Distribution Goes Public
Cardinal Distribution Inc. completed its initial public offering on the NASDAQ at $1.03 per share, providing capital for continued expansion through acquisitions.
1984Cardinal Health
Acquisition of Ellicott Drug
Cardinal acquired Ellicott Drug, a pharmaceutical distributor in Buffalo, New York, continuing the acquisition-driven expansion strategy that would define the company's growth for decades.
1988Cardinal Health
Sale of Food Operations to Roundy's Inc.
Cardinal sold its remaining food operations to Roundy's Inc., completing the company's transition from a diversified food and drug distributor to a pure-play pharmaceutical distribution company.
1994Cardinal Health
Name Change to Cardinal Health
The company changed its name from Cardinal Distribution to Cardinal Health, reflecting its expanding mission beyond pure distribution into healthcare services, manufacturing, and technology. Revenues exceeded $1 billion by 1991.
1995Cardinal Health
Acquisition of Medicine Shoppe International
Cardinal acquired Medicine Shoppe International, the country's largest franchise of retail pharmacies, marking the company's first significant non-distribution acquisition and entry into retail pharmacy.
1996Cardinal Health
Acquisition of Pyxis Corp.
Cardinal acquired Pyxis Corp., a manufacturer of automated supply and pharmaceutical dispensing systems for hospitals, adding medical technology capabilities to the company's portfolio.
1999Cardinal Health
Acquisition of Allegiance Healthcare Corp.
Cardinal acquired Allegiance Healthcare Corp. for approximately $4.4 billion, becoming a major player in the medical-surgical products market and establishing the foundation for what would become the Global Medical Products and Distribution segment.
2008Roche
Severin Schwan becomes CEO
Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.
2009Roche
Full Acquisition of Genentech for $46.8 Billion
Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.
2013Cardinal Health
Red Oak Sourcing Joint Venture with CVS
Cardinal Health and CVS Caremark announced the creation of Red Oak Sourcing, a 50/50 joint venture to form the largest generic pharmaceutical sourcing entity in the United States. The venture began operations in July 2014 with an initial 10-year term.
2014Cardinal Health
Loss of Walgreens Contract
Cardinal Health lost a major pharmaceutical distribution contract with Walgreens, which shifted its distribution to AmerisourceBergen. The contract had generated $3.3 billion in quarterly revenue.
2017Cardinal Health
Acquisition of Patient Recovery Business from Medtronic
Cardinal Health acquired the Patient Recovery business from Medtronic for $6.1 billion, expanding its medical products portfolio and adding significant scale to the Global Medical Products and Distribution segment.
2018Roche
Foundation Medicine & Flatiron Health Acquisitions
Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.
2023Roche
Acquired Telavant
F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.
2024Cardinal Health
OptumRx Contract Non-Renewal Announced
Cardinal Health's pharmaceutical distribution contracts with OptumRx (part of UnitedHealth Group) expired at the end of June 2024 and were not renewed. They represented about $38.1 billion of fiscal 2024 revenue.
2025Cardinal Health
Fiscal 2025 Results and Raised FY2026 Guidance
Cardinal Health reported fiscal 2025 revenue of $222.6 billion, down about 2% after the OptumRx contract expiration, while net earnings rose to about $1.6 billion.
2025Roche
Group Sales Reach CHF 61.5 Billion
Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.
2026Cardinal Health
Fiscal 2026 Revenue Reaches $254.2 Billion
Fiscal 2026 revenue rose 14% to $254.2 billion and non-GAAP EPS rose 37% to $11.26, with profit growth in all five operating segments.
Acquisitions
Cardinal Health
- Advanced Diabetes Supply Group (ADSG)2025$1.1B
- Solaris Health (via The Specialty Alliance)2025$1.9B
- Integrated Oncology Network (ION)2024Undisclosed
- GI Alliance (71% stake)2024$2.8B
- Patient Recovery Business from Medtronic2017$6.1B
- Allegiance Healthcare Corp.1999Undisclosed
Roche
- PathAI2026$1.1B
- 89bio2025$3.5B
- Telavant2023$7.1B
- Carmot Therapeutics2023$2.7B
- Foundation Medicine2018$2.4B
- ForSight VISION42017Undisclosed
Questions about Cardinal Health vs Roche
Who is the CEO of Cardinal Health, Inc. and F. Hoffmann-La Roche AG?
Cardinal Health, Inc. is led by Jason M. Hollar and F. Hoffmann-La Roche AG is led by Thomas Schinecker. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Cardinal Health, Inc. founded vs F. Hoffmann-La Roche AG?
F. Hoffmann-La Roche AG was founded in 1896 — 75 years before Cardinal Health, Inc., which was founded in 1971. F. Hoffmann-La Roche AG's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Cardinal Health, Inc..
How many employees does Cardinal Health, Inc. have compared to F. Hoffmann-La Roche AG?
Cardinal Health, Inc. employs approximately 63,900 people, while F. Hoffmann-La Roche AG employs approximately 112,774. F. Hoffmann-La Roche AG has the larger workforce at 112,774 employees, compared to Cardinal Health, Inc.'s 63,900. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Cardinal Health, Inc. and F. Hoffmann-La Roche AG headquartered?
Cardinal Health, Inc. is headquartered in United States and F. Hoffmann-La Roche AG is headquartered in Switzerland. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded Cardinal Health, Inc. and F. Hoffmann-La Roche AG?
Cardinal Health, Inc. was founded by Robert D. Walter. F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche.
Which company has a longer operating history — Cardinal Health, Inc. or F. Hoffmann-La Roche AG?
F. Hoffmann-La Roche AG has been operating for approximately 130 years, making it the more established of the two companies. Cardinal Health, Inc. has been in operation for around 55 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Cardinal Health vs Roche overview